BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24243914)

  • 1. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
    Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
    Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
    J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.
    Dequesada IM; Quisling RG; Yachnis A; Friedman WA
    Neurosurgery; 2008 Nov; 63(5):898-903; discussion 904. PubMed ID: 19005380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
    Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
    Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
    Mitsuya K; Nakasu Y; Horiguchi S; Harada H; Nishimura T; Bando E; Okawa H; Furukawa Y; Hirai T; Endo M
    J Neurooncol; 2010 Aug; 99(1):81-8. PubMed ID: 20058049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
    Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
    J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What predicts early volumetric edema increase following stereotactic radiosurgery for brain metastases?
    Hanna A; Boggs DH; Kwok Y; Simard M; Regine WF; Mehta M
    J Neurooncol; 2016 Apr; 127(2):303-11. PubMed ID: 26721241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects.
    Diao K; Bian SX; Routman DM; Yu C; Kim PE; Wagle NA; Wong MK; Zada G; Chang EL
    J Neurosurg; 2018 Dec; 129(6):1397-1406. PubMed ID: 29303446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.
    Fujimoto D; von Eyben R; Gibbs IC; Chang SD; Li G; Harsh GR; Hancock S; Fischbein N; Soltys SG
    J Neurooncol; 2018 Jan; 136(1):207-212. PubMed ID: 29098569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Peng L; Parekh V; Huang P; Lin DD; Sheikh K; Baker B; Kirschbaum T; Silvestri F; Son J; Robinson A; Huang E; Ames H; Grimm J; Chen L; Shen C; Soike M; McTyre E; Redmond K; Lim M; Lee J; Jacobs MA; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1236-1243. PubMed ID: 30353872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
    Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
    Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS).
    Tini P; Nardone V; Pastina P; Battaglia G; Vinciguerra C; Carfagno T; Rubino G; Carbone SF; Sebaste L; Cerase A; Federico A; Pirtoli L
    Neurol Sci; 2017 Jun; 38(6):975-982. PubMed ID: 28260188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
    Patsouris A; Augereau P; Tanguy JY; Morel O; Menei P; Rousseau A; Paumier A
    Cancer Radiother; 2014 Mar; 18(2):142-6. PubMed ID: 24433952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-stereotactic radiosurgery brain metastases: a review.
    Fabiano AJ; Qiu J
    J Neurosurg Sci; 2015 Jun; 59(2):157-67. PubMed ID: 25600555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.